Neuropathix, Inc. Announces Publication of Validated Preclinical Studies on KLS-13019 in the British Journal of Pharmacology

May 6, 2021

Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement

April 14, 2026
PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology

April 13, 2026
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.

April 13, 2026
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

April 13, 2026